BridgeMD
New treatment option for Chronic Migraine
Official title Laser Acupuncture for Chronic Migraine
ClinicalTrials.gov ID: NCT06219694
What this study is testing
- What it's testing
- A single-blind randomized controlled trial was conducted from October 2024 to May 2025. Chronic migraine patients were randomly assigned in a 1:1 ratio to receive either Laser acupuncture or sham treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- patients aged above 20 years old and had CM managed pharmacologically, including preventive and/or acute migraine medications, and in addition, those...
- patients who had unsatisfactory effect of current pharmacological treatments, defined as they self-reported
- patients who had a minimum of one-year history of migraine with or without aura.
You likely can't join if
- patients who had received another LA therapy or traditional acupuncture at baseline
- migraine onset after the age of 50
- cognitive or psychological impairment interfering with the participant's ability to receive LA protocol and describe symptoms
- patients with missing data at baseline or during the follow-up period.
The study team makes the final eligibility decision.
Where it's taking place
- Taichung, Xitun District, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taichung, Xitun District, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.